ArticleACS medicinal chemistry letters2024

Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.